NCT01652326View on ClinicalTrials.gov

Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

CompletedOBSERVATIONAL
Enrollment

792

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Alcohol Withdrawal Syndrome
Interventions
DRUG

Diazepam

Trial Locations (1)

15213

UPMC, Pittsburgh

All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT01652326 - Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome | Biotech Hunter | Biotech Hunter